Astra Aims to File for U.S. Covid Vaccine License This Fall (3)

AstraZeneca Plc won’t seek a U.S. license for its Covid-19 vaccine until the autumn at the earliest, according to its chief executive officer, falling further behind rivals whose shots secured emergency authorizations.

The company plans to file an application to the U.S. Food and Drug Administration in the next two to three months, CEO Pascal Soriot said in a Bloomberg TV interview Thursday, adding that he hopes to gain approval “relatively quickly.”

News of the delay comes as Astra is mulling the next steps for its vaccines business, according to a person with knowledge of the situation, who didn’t want ...